Cargando…
Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database
Background: The prevalence of exposure to pharmacogenomic medications is well established but little is known about how long patients are exposed to these medications. Aim: Our objective was to describe the amount of exposure to actionable pharmacogenomic medications using patient-level measures amo...
Autores principales: | Bianchini, Monica L., Aquilante, Christina L., Kao, David P., Martin, James L., Anderson, Heather D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672722/ https://www.ncbi.nlm.nih.gov/pubmed/38003889 http://dx.doi.org/10.3390/jpm13111574 |
Ejemplares similares
-
Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraception
por: Lazorwitz, Aaron, et al.
Publicado: (2021) -
The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
por: Cha, Yu-Jin
Publicado: (2018) -
Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database
por: Bouée, Stéphane, et al.
Publicado: (2016) -
Linkage Rate Between Data From Health Checks and Health Insurance Claims in the Japan National Database
Publicado: (2014) -
Use of the dental formula from the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Tsuneishi, Midori, et al.
Publicado: (2022)